文章名稱(chēng)引用次數(shù)

• Long-acting injectable second-generation antipsychotics in first-episode psychosis: a narrative review5
• The effects of brexpiprazole and aripiprazole on body weight as monotherapy in patients with schizophrenia and as adjunctive treatment in patients with major depressive disorder: an analysis of short-term and long-term studies5
• Efficacy and acceptability of antidepressants in patients with ischemic heart disease: systematic review and meta-analysis4
• Need to bleed? Clozapine haematological monitoring approaches a time for change4
• A phase II study to evaluate the pharmacokinetics, safety, and tolerability of Risperidone ISM multiple intramuscular injections once every 4 weeks in patients with schizophrenia3
• Switching antipsychotic treatment to aripiprazole in psychotic patients with neuroleptic-induced tardive dyskinesia: a 24-week follow-up study3
• The use of (newer) antipsychotics in bipolar inpatients over a 17-year observation period3
• Real-world data on paliperidone palmitate for the treatment of schizophrenia and other psychotic disorders: a systematic review of randomized and nonrandomized studies3
• The effect of selective serotonin reuptake inhibitors on major adverse cardiovascular events: a meta-analysis of randomized-controlled studies in depression2
• Sex and body weight are major determinants of venlafaxine pharmacokinetics2